A groundbreaking new study, led by experts at the University of Nottingham, has found that…
DISEASES
UC Riverside studies reveal PTPN2’s role in keeping harmful bacteria in check and preventing inflammation…
When lung cancer treatment stops working, what happens next? New research reveals the answer may…
A*STAR team identifies druggable molecular target that could enhance treatment for EGFR-mutant lung cancers prevalent…
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in…
Health and medicine is more than just biological – societal forces can get under your…
With a new study in the journal Science Bulletin, researchers at Sun Yat-Sen Memorial Hospital, Sun…
Study of 12.6 million births shows 36% jump in past decade Gestational diabetes raises health…
Researchers identified new drug combination that could overcome treatment resistance in acute myeloid leukemia A…
Cedars-Sinai investigators develop tool to help physicians determine which pancreatic neuroendocrine tumor patients are at…
